N of 1 trials and the optimal individualisation of drug treatments: a systematic review protocol

DiscussionThis review will provide new insights into the clinical utility of N of 1 drug trials in helping participants find the most acceptable treatment as defined by patients and clinicians based on the selected outcome measures and the perspectives of participants involved in such trials. Findings from this review will inform the development of a stakeholder workshop and guidance to help physicians find the optimum therapy for their patients and will help guide future research on N of 1 trials.Systematic review registrationPROSPEROCRD42016032452
Source: Systematic Reviews - Category: Global & Universal Source Type: research